|
KPTI Karyopharm Therapeutics Inc 1503802 |
| Balance Sheet |
|
Current Assets
|
$126,333,000.00 |
|
Assets
|
$131,417,000.00 |
|
Current Liabilities
|
$117,302,000.00 |
|
Liabilities
|
$397,063,000.00 |
|
Equity
|
$-265,646,000.00 |
|
Shares Out
|
22544000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-22,728,000.00 |
|
Investing Cash Flow
|
$3,200,000.00 |
| Market Analysis |
Market Cap
|
$158,033,440.00 |
|
Price
|
$1.92 |
|
PB
|
1.82 |
|
EPS
|
-1.02 |
|
PS
|
1.54 |
|
FCF
|
$-22,728,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:34 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:31 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-12 |
-5.71 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-14 |
-1.24 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-4.32 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-03 |
-3.82 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KPTI documents filed with the SEC.
KPTI Filings
Clear
